BWAY earnings: next report 2026-08-12, real EPS beat/miss history, analyst consensus Buy, P/E 72.16. Updated 2026-07-23.
BrainsWay (BWAY) Research Hub
BrainsWay (BWAY) trades on NASDAQ, IL in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 13.93 USD (-3.33%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 72.16, market cap 0.64B. This hub links to the full technical, earnings and options research available for BWAY.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, IL |
| Last close | 13.93 USD (-3.33%) |
| 52-week range | 13.8 USD – 17.29 USD |
| Trend regime | Range |
| 14-day RSI | 35.9 (Bearish) |
| Trailing P/E | 72.16 |
| Market cap | 0.64B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for BWAY
Covered Call on BWAY: how it works, illustrative setup around the real 13.93 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BWAY: how it works, illustrative setup around the real 13.93 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BWAY: how it works, illustrative setup around the real 13.93 USD price, max profit/loss, breakeven and when to use it. Educational.
BWAY technical analysis: range, last 13.93 USD, RSI 35.9, 52w range 13.8 USD–17.29 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is BWAY in?
BrainsWay (BWAY) is classified under Healthcare (Medical - Devices), listed on NASDAQ, IL.
Is BWAY in an uptrend or downtrend?
As of 2026-09-11, BWAY is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BWAY's trailing P/E ratio?
BWAY's trailing P/E is 72.16, with a market cap of 0.64B. See the earnings research page for full valuation detail.
When does BWAY next report earnings?
BWAY is next scheduled to report earnings on 2026-08-12, with a consensus EPS estimate of 0.1 USD.